Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty

Trial Profile

Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Anaesthesia; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 19 Mar 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 02 Dec 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 02 Dec 2014 Planned End Date changed from 1 Feb 2015 to 1 May 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top